A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control

The combination of immune-stimulating strategies has the potency to improve immunotherapy of cancer. Vaccination against neoepitopes derived from patient tumor material can generate tumor-specific T cell immunity, which could reinforce the efficacy of checkpoint inhibitor therapies such as anti-PD-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Tondini, Elena, Arakelian, Tsolere, Oosterhuis, Koen, Camps, Marcel, van Duikeren, Suzanne, Han, Wanda, Arens, Ramon, Zondag, Gerben, van Bergen, Jeroen, Ossendorp, Ferry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791440/
https://www.ncbi.nlm.nih.gov/pubmed/31646082
http://dx.doi.org/10.1080/2162402X.2019.1652539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791440/
https://www.ncbi.nlm.nih.gov/pubmed/31646082
http://dx.doi.org/10.1080/2162402X.2019.1652539

Ejemplares similares